| -- End Ad Box ---> | | | | generic and OTC drugs will inflate in Brazil, as a |
| According to our new research report Brazil | | | | number of drugs will lose their patents. The report also |
| Healthcare Market Analysis, the pharmaceutical | | | | gives an insight into the role of government in the |
| industry in Brazil has been continuously growing for the | | | | regulation of pharmaceutical companies. |
| last few years although the concerns of high taxes on | | | | Our research indicates that the Brazilian healthcare |
| medicines present negative conditions. This strong | | | | industry shows immense growth potential and requires |
| growth could be attributed to the fact that the private | | | | the attention of existing as well as new players. There |
| players are making huge investments in this sector as | | | | is a high demand for hospitals services and |
| Brazil has been graded as one of the most promising | | | | experienced healthcare professionals. Besides, the |
| pharmerging countries across the world. Therefore, the | | | | country is highly dependent on imported drugs, thereby |
| future of this industry remains pleasantly buoyant with | | | | giving room to the private players to set up their own |
| a CAGR of around 14% during 2010-2013. | | | | manufacturing capacities in the country. It also gives an |
| We have done an extensive research and prudent | | | | overview of the factors that may hinder the |
| analysis of the Brazilian pharmaceutical industry in | | | | healthcare industry growth in coming years. |
| order to understand the factors that will continue to | | | | Our report Brazil Healthcare Market Analysis" |
| serve as growth drivers over the forecast period | | | | provides comprehensive information about the recent |
| (2010-2013). Several factors such as growing | | | | market trends, future growth scenario and authentic |
| healthcare spending and the epidemiological transitions | | | | statistics for different segments of the Brazilian |
| have been resulting into the strong demand for | | | | healthcare industry. The report has thoroughly |
| high-priced drugs and expensive therapies. Moreover, | | | | examined industrial developments and competitive |
| the soaring demand for primary health care level drugs | | | | landscapes to enable clients understand the market |
| such as generics, antibiotics and OTC drugs will drive | | | | structure and its progress in coming years. |
| the industry growth in coming years. Demand for | | | | |